The role of stress-induced dyssynchrony obtained from nuclear modalities in evaluation of high-risk patients after surgical treatment of ischemic cardiomyopathy

Funding Acknowledgements Type of funding sources: None. Background Mechanical dyssynchrony (MD) is a well-known parameter witch has prognostic value [1]. Stress tests can be used to unmask MD. However, stress-induced changes in left ventricle (LV) MD by data of nuclear imaging modalities are not well-understood, especially its predictive value [2]. Purpose. To assess the role of stress-induced changes of LV MD obtained by nuclear modalities in evaluating high-risk patients after surgical treatment of ischemic cardiomyopathy (ICM). Methods. Sixty-nine patients with ICM were enrolled. Before surgical treatment all patients underwent gated myocardial perfusion imaging (gMPI) (Tc99m-MIBI; 2 days stress-rest protocol, adenosine 140mkg/kg/min) and gated blood pool SPECT (gBPS) (rest – stress, dobutamine doses of 5/10/15 µg/kg/min). After surgical treatment patients were divided into 2 groups: with (n = 21) and without (n = 48) complicated course of early postoperative period (death, intra-aortic balloon pump, extra inotropic support). The following parameters were estimated: summed stress score (SSS), summed rest score (SRS), summed different score (SDS); phase mean, phase standard deviation (PSD) and histogram bandwidth (HBW) (% from cycle for MPI; degrees for gBPS); phase entropy (%, only by gBPS). Stress-induced changes (Δ) were calculated for MPI indices as [stress value-rest value], for gBPS indices as [value on each dobutamine dose-rest value]. For gBPS the maximum changes of MD were calculated as well. Results. Rest gBPS MD correlated with SRS better than rest gMPI (gMPI: PSD r = 0.31, p = 0.005; HBW r = 0.28, p = 0.008; gBPS: PSD r = 0.47, p < 0.001; HBW r = 0.36, p = 0.006; entropy r = 0.39, p = 0.003). Stress gBPS MD correlated better with post stress gMPI MD at the dobutamine dose of 5µg/kg/min. An following increase of the dobutamine dose led to a decrease in the r-value, but it remained significant for all indices (tab.1). Stress-induced MD changes didn’t correlate between gMPI and gBPS. Mann-Whitney test showed significant differences in SDS (p = 0.02) between the groups. Both methods didn’t show any differences at rest study. Stress-induced changes of MD showed differences between groups in only ΔEntropy rest-10µg/kg/min (p = 0.02) and maximum ΔEntropy (p = 0.01) by gBPS, as well as Δphase mean (p = 0.03) by gMPI. Logistic regression analysis showed that only maximum ΔEntropy has prognostic value in prediction of the course of early postoperative period (OR 1.2 95%CI 1.04; 1.37). ROC-analysis showed sensitivity of 80% and specificity of 55% with AUC of 0.7 for cut-off value >0. Conclusion. LVMD obtained from gBPS is associated with SRS better than those obtained from gMPI. Dyssynchrony indices obtained from gMPI with adenosine stress-test have a week to moderate correlation with those obtained from dobutamine gBPS, and correlation decrease with increasing of dobutamine dose. Only maximum ΔEntropy obtained from dobutamine gBPS is associated with the adverse course of early postoperative period in patients with ICM.

Impact of Intraprocedural Pressor Use on Catheter Ablation for Ventricular Tachycardia

Background: Ventricular tachycardia (VT) remains a leading cause of morbidity and sudden death. Improvements in catheter ablation have significantly advanced this option as a treatment method for refractory VT. Despite advances, use and impact of inotrope and vasodepressor medicines as part of intraprodcedural management during VT ablation have been understudied. Methods: We conducted a exploratory, retrospective analysis of consecutive patients undergoing VT ablation. Patient, intra and peri-procedural data, focusing on pressor use and hemodynamics through ablation, and procedural endpoint data were collected. Results: From 2014-2017, 149 patients underwent VT ablation of which 67% exhibited cardiomyopathy (53% ischemic). Most procedures (71%) were conducted under general anesthesia. In those with cardiomyopathy, steady-state use of dobutamine and dopamine was more common though substantial use of phenylephrine was noted. In adjusted analyses, (1) dobutamine was associated with increased procedure time (402.5±18.8 vs 347.2±14.0 min, p = 0.03), (2) dopamine was associated with increased number of distinct VTs (2.8 vs. 2.2, p<0.001) while both dopamine and dobutamined resulted in increased intra-procedural cardioversions (1.3 vs. 0.6, p<0.001 and 1.34 vs. 0.66, p=0.001, respectively) and (3) dobutamine dose exhibited a linear correlation with post-ablation length of stay. Conclusions: In this exploratory work, we sought to understand effects of hemodynamic drug use on short-term, procedural outcomes of VT ablation. Salient findings include: (1) arrhythmogenic nature of inotropes resulting in an increase in intraprocedural cardioversions, (2) greater propensity for induction of non-clinical VTs with use of intraprocedural dopamine and (3) substantial use of phenylephrine in those with underlying cardiomyopathy.

Cardiac function following prolonged exercise: influence of age

This study sought to determine the influence of age on the left ventricular (LV) response to prolonged exercise (PE; 150 min). LV systolic and diastolic performance was assessed using echocardiography (ECHO) before (pre) and 60 min following (post) exercise performed at 80% maximal aerobic power in young (28 ± 4.5 years; n = 18; mean ± SD) and middle-aged (52 ± 3.9 years; n = 18) participants. LV performance was assessed using two-dimensional ECHO, including speckle-tracking imaging, to determine LV strain (LV S) and LV S rate (LV SR), in addition to Doppler measures of diastolic function. We observed a postexercise elevation in LV S (young: −19.5 ± 2.1% vs. −21.6 ± 2.1%; middle-aged: −19.9 ± 2.3% vs. −20.8 ± 2.1%; P < 0.05) and LV SR (young: −1.19 ± 0.1 vs. −1.37 ± 0.2; middle-aged: −1.20 ± 0.2 vs. −1.38 ± 0.2; P < 0.05) during recovery in both groups. Diastolic function was reduced during recovery, including the LV SR ratio of early-to-late atrial diastolic filling (SRe/a), in young (2.35 ± 0.7 vs. 1.89 ± 0.5; P < 0.01) and middle-aged (1.51 ± 0.5 vs. 1.05 ± 0.2; P < 0.01) participants, as were conventional indices including the E/A ratio. Dobutamine stress ECHO revealed a postexercise depression in LV S in response to increasing dobutamine dose, which was similar in both young (pre-exercise dobutamine 0 vs. 20 μg·kg−1·min−1: −19.5 ± 2.1 vs. −27.2 ± 2.2%; postexercise dobutamine 0 vs. 20 μg·kg−1·min−1: −21.6 ± 2.1 vs. −23.7 ± 2.2%; P < 0.05) and middle-aged participants (pre: −19.9 ± 2.3 vs. −25.3 ± 2.7%; post: −20.8 ± 2.1 vs. −23.5 ± 2.7; P < 0.05). This was despite higher noradrenaline concentrations immediately postexercise in the middle-aged participants compared with young (4.26 ± 2.7 nmol/L vs. 3.00 ± 1.4 nmol/L; P = 0.12). These data indicate that LV dysfunction is observed following PE and that advancing age does not increase the magnitude of this response.

Effects of Dobutamine on Hemodynamics and Left Ventricular Performance after Cardiopulmonary Bypass in Cardiac Surgical Patients

Background Dobutamine is commonly used to improve ventricular performance after cardiopulmonary bypass. The authors determined the effect of dobutamine on hemodynamics and left ventricular performance immediately after cardiopulmonary bypass in patients undergoing coronary artery bypass graft surgery. Methods One hundred patients received sequential 3-min infusions of dobutamine at 0-40 microg x kg(-1) x min(-1) immediately after cardiopulmonary bypass. Ten additional patients who received no dobutamine served as controls. Hemodynamics and left ventricular performance (fractional area change by transesophageal echocardiography, stroke volume index, and thermodilution cardiac index) were measured. Mixed-effects modeling accounted for repeated-measures data and interindividual differences and allowed for potential effects of covariates. Results Heart rate increased in a dose-dependent manner. The slope of HR versus dobutamine dose was steeper in individuals in whom peak dobutamine dose was not reached compared with that in the remaining individuals; slope decreased 2.71 +/- 0.68% per year of age. Dobutamine affected blood pressure minimally, but slightly decreased pulmonary capillary wedge pressure and central venous pressure. Systemic vascular resistance initially increased with dobutamine 10 microg x kg(-1) x min(-1) and remained constant with larger doses. Dobutamine produced a dose-dependent increase in left ventricular performance, primarily by increasing heart rate, because stroke volume index decreased with dobutamine dose. Conclusion Our results suggest that the response to graded dobutamine infusion in the post-cardiopulmonary bypass period differs from that previously reported. After cardiopulmonary bypass, the dominant mechanism by which dobutamine improves left ventricular performance is by increasing heart rate. Dobutamine affects blood pressure minimally.